Back to Search
JUAN BADIMON, PHD
PHD
Health Educator
NPI: 1376385500Individual
Specialties, Licenses & Credentials
Health EducatorPrimary
Health Educator
Code: 174H00000X
Clinical Trials (6)
6
Linked Trials
0
Recruiting
4
With Results
Antithrombotic Activities of Sotagliflozin vs. Empagliflozin
NCT06618976ACTIVE_NOT_RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR
Sotagliflozin in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients
NCT05562063COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).
NCT03485222COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients
NCT01823510COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Reversing Ticagrelor's Effects With Fresh Platelets
NCT02201394COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Antithrombotic Effects of Ticagrelor Versus Clopidogrel
NCT01642238COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial.
PMID 39907687·Eur Heart J·2025
2-rct
Rationale and Design of the SOTA-THROMBOSIS Trial (ATRU-VI): Antithrombotic Activities of Sotagliflozin Compared With Empagliflozin.
PMID 40748666·J Cardiovasc Pharmacol·2025
8-other
Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failure.
PMID 39196095·Nat Cardiovasc Res·2023
2-rct
Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis.
PMID 34693515·Cochrane Database Syst Rev·2021
1-meta
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study.
PMID 34325888·JACC Heart Fail·2021
2-rct
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction.
PMID 33197559·J Am Coll Cardiol·2021
2-rct
Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease.
PMID 28837213·Thromb Haemost·2017
4-observational
Impact of Timing on the Functional Recovery Achieved With Platelet Supplementation After Treatment With Ticagrelor.
PMID 28768756·Circ Cardiovasc Interv·2017
3-trial
Ticagrelor reduces thrombus formation more than clopidogrel, even when co-administered with bivalirudin.
PMID 25104302·Thromb Haemost·2014
4-observational
Genesis and dynamics of atherosclerotic lesions: implications for early detection.
PMID 19342832·Cerebrovasc Dis·2009
6-review
Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I(Milano).
PMID 19120689·J Cell Mol Med·2009
7-preclinical
Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay.
PMID 19220730·J Thromb Haemost·2009
8-other
In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis.
PMID 18979182·Int J Cardiovasc Imaging·2009
7-preclinical
Quantification of serial changes in plaque burden using multi-detector computed tomography in experimental atherosclerosis.
PMID 18466906·Atherosclerosis·2009
7-preclinical
HDL-cholesterol: is it really good? Differences between apoA-I and HDL.
PMID 18547543·Biochem Pharmacol·2008
6-review
Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease.
PMID 18612541·Thromb Haemost·2008
4-observational
The presence of coronary artery disease increases platelet-dependent thrombosis in patients with type 2 diabetes mellitus.
PMID 18983525·J Thromb Haemost·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 GUSTAVE L LEVY PL # 1030
NEW YORK, NY 10029 - Phone
- (212) 241-8484
Quick Facts
- NPI
- 1376385500
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile